Clinical Trials List
Protocol NumberCKJX839C12301
Completed
2021-01-01 - 2023-09-30
Phase III
Recruiting2
ICD-10E78.0
Pure hypercholesterolemia
ICD-9272.0
Pure hypercholesterolemia
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Min-Ji Charng Division of Cardiovascular Diseases
- Wen-Chung Yu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
2 participants
-
Global
102 participants
